Literature DB >> 11278474

The glial and the neuronal glycine transporters differ in their reactivity to sulfhydryl reagents.

M J Roux1, R Martinez-Maza, A Le Goff, B Lopez-Corcuera, C Aragon, S Supplisson.   

Abstract

The neuronal (GlyT2) and glial (GlyT1) glycine transporters, two members of the Na(+)/Cl(-)-dependent neurotransmitter transporter superfamily, differ by many aspects, such as substrate specificity and Na(+) coupling. We have characterized under voltage clamp their reactivity toward the membrane impermeant sulfhydryl reagent [2-(trimethylammonium)-ethyl]-methanethiosulfonate (MTSET). In Xenopus oocytes expressing GlyT1b, application of MTSET reduced to the same extent the Na(+)-dependent charge movement, the glycine-evoked current, and the glycine uptake, indicating a complete inactivation of the transporters following cysteine modification. In contrast, this compound had no detectable effect on the glycine uptake and the glycine-evoked current of GlyT2a. The sensitivities to MTSET of the two transporters can be permutated by suppressing a cysteine (C62A) in the first extracellular loop (EL1) of GlyT1b and introducing one at the equivalent position in GlyT2a, either by point mutation (A223C) or by swapping the EL1 sequence (GlyT1b-EL1 and GlyT2a-EL1) resulting in AFQ <--> CYR modification. Inactivation by MTSET was five times faster in GlyT2a-A223C than in GlyT2a-EL1 or GlyT1b, suggesting that the arginine in position +2 reduced the cysteine reactivity. Protection assays indicate that EL1 cysteines are less accessible in the presence of all co-transported substrates: Na(+), Cl(-), and glycine. Application of dithioerythritol reverses the inactivation by MTSET of the sensitive transporters. Together, these results indicate that EL1 conformation differs between GlyT1b and GlyT2a and is modified by substrate binding and translocation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278474      PMCID: PMC2375918          DOI: 10.1074/jbc.M009196200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Ion binding and permeation at the GABA transporter GAT1.

Authors:  S Mager; N Kleinberger-Doron; G I Keshet; N Davidson; B I Kanner; H A Lester
Journal:  J Neurosci       Date:  1996-09-01       Impact factor: 6.167

2.  Analysis of the transmembrane topology and membrane assembly of the GAT-1 gamma-aminobutyric acid transporter.

Authors:  J A Clark
Journal:  J Biol Chem       Date:  1997-06-06       Impact factor: 5.157

3.  The membrane topology of GAT-1, a (Na+ + Cl-)-coupled gamma-aminobutyric acid transporter from rat brain.

Authors:  E R Bennett; B I Kanner
Journal:  J Biol Chem       Date:  1997-01-10       Impact factor: 5.157

4.  Analysis of the transmembrane topology of the glycine transporter GLYT1.

Authors:  L Olivares; C Aragón; C Giménez; F Zafra
Journal:  J Biol Chem       Date:  1997-01-10       Impact factor: 5.157

5.  Determination of external loop topology in the serotonin transporter by site-directed chemical labeling.

Authors:  J G Chen; S Liu-Chen; G Rudnick
Journal:  J Biol Chem       Date:  1998-05-15       Impact factor: 5.157

6.  Control of NMDA receptor activation by a glycine transporter co-expressed in Xenopus oocytes.

Authors:  S Supplisson; C Bergman
Journal:  J Neurosci       Date:  1997-06-15       Impact factor: 6.167

7.  External cysteine residues in the serotonin transporter.

Authors:  J G Chen; S Liu-Chen; G Rudnick
Journal:  Biochemistry       Date:  1997-02-11       Impact factor: 3.162

Review 8.  Probing the structural and functional domains of the CFTR chloride channel.

Authors:  M H Akabas; M Cheung; R Guinamard
Journal:  J Bioenerg Biomembr       Date:  1997-10       Impact factor: 2.945

9.  Locating the anion-selectivity filter of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel.

Authors:  M Cheung; M H Akabas
Journal:  J Gen Physiol       Date:  1997-03       Impact factor: 4.086

10.  Structure of the NMDA receptor channel M2 segment inferred from the accessibility of substituted cysteines.

Authors:  T Kuner; L P Wollmuth; A Karlin; P H Seeburg; B Sakmann
Journal:  Neuron       Date:  1996-08       Impact factor: 17.173

View more
  8 in total

1.  Transient currents in the glycine cotransporter GlyT1 reveal different steps in transport mechanism.

Authors:  Francesca Cherubino; Elena Bossi; Andreea Miszner; Chiara Ghezzi; Antonio Peres
Journal:  J Mol Neurosci       Date:  2009-08-27       Impact factor: 3.444

2.  Neurotransmitter- and Release-Mode-Specific Modulation of Inhibitory Transmission by Group I Metabotropic Glutamate Receptors in Central Auditory Neurons of the Mouse.

Authors:  Rebecca J Curry; Kang Peng; Yong Lu
Journal:  J Neurosci       Date:  2018-08-09       Impact factor: 6.167

3.  Dynamics of forward and reverse transport by the glial glycine transporter, glyt1b.

Authors:  Karin R Aubrey; Robert J Vandenberg; John D Clements
Journal:  Biophys J       Date:  2005-06-10       Impact factor: 4.033

4.  Flux coupling, not specificity, shapes the transport and phylogeny of SLC6 glycine transporters.

Authors:  Bastien Le Guellec; France Rousseau; Marion Bied; Stéphane Supplisson
Journal:  Proc Natl Acad Sci U S A       Date:  2022-10-03       Impact factor: 12.779

5.  Functional consequences of sulfhydryl modification of the γ-aminobutyric acid transporter 1 at a single solvent-exposed cysteine residue.

Authors:  Jaison J Omoto; Matthew J Maestas; Ali Rahnama-Vaghef; Ye E Choi; Gerardo Salto; Rachel V Sanchez; Cynthia M Anderson; Sepehr Eskandari
Journal:  J Membr Biol       Date:  2012-08-24       Impact factor: 1.843

6.  Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease.

Authors:  Eloisa Carta; Seo-Kyung Chung; Victoria M James; Angela Robinson; Jennifer L Gill; Nathalie Remy; Jean-François Vanbellinghen; Cheney J G Drew; Sophie Cagdas; Duncan Cameron; Frances M Cowan; Mireria Del Toro; Gail E Graham; Adnan Y Manzur; Amira Masri; Serge Rivera; Emmanuel Scalais; Rita Shiang; Kate Sinclair; Catriona A Stuart; Marina A J Tijssen; Grahame Wise; Sameer M Zuberi; Kirsten Harvey; Brian R Pearce; Maya Topf; Rhys H Thomas; Stéphane Supplisson; Mark I Rees; Robert J Harvey
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

7.  Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease.

Authors:  Mark I Rees; Kirsten Harvey; Brian R Pearce; Seo-Kyung Chung; Ian C Duguid; Philip Thomas; Sarah Beatty; Gail E Graham; Linlea Armstrong; Rita Shiang; Kim J Abbott; Sameer M Zuberi; John B P Stephenson; Michael J Owen; Marina A J Tijssen; Arn M J M van den Maagdenberg; Trevor G Smart; Stéphane Supplisson; Robert J Harvey
Journal:  Nat Genet       Date:  2006-06-04       Impact factor: 38.330

8.  Pharmacological Evidence on Augmented Antiallodynia Following Systemic Co-Treatment with GlyT-1 and GlyT-2 Inhibitors in Rat Neuropathic Pain Model.

Authors:  Amir Mohammadzadeh; Péter P Lakatos; Mihály Balogh; Ferenc Zádor; Dávid Árpád Karádi; Zoltán S Zádori; Kornél Király; Anna Rita Galambos; Szilvia Barsi; Pál Riba; Sándor Benyhe; László Köles; Tamás Tábi; Éva Szökő; Laszlo G Harsing; Mahmoud Al-Khrasani
Journal:  Int J Mol Sci       Date:  2021-03-01       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.